company background image
EW

Edwards Lifesciences NYSE:EW Stock Report

Last Price

US$84.51

Market Cap

US$52.2b

7D

8.2%

1Y

-24.7%

Updated

03 Feb, 2023

Data

Company Financials +

Edwards Lifesciences Corporation

NYSE:EW Stock Report

Mkt Cap: US$52.2b

EW Stock Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.

EW fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance4/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Edwards Lifesciences Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Edwards Lifesciences
Historical stock prices
Current Share PriceUS$84.51
52 Week HighUS$131.10
52 Week LowUS$67.13
Beta1.01
1 Month Change10.51%
3 Month Change23.30%
1 Year Change-24.67%
3 Year Change9.09%
5 Year Change100.78%
Change since IPO6,046.18%

Recent News & Updates

Edwards Lifesciences slips as Piper downgrades on challenging setup

Jan 30

Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity

Jan 18

Recent updates

Edwards Lifesciences slips as Piper downgrades on challenging setup

Jan 30

Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity

Jan 18

Edwards Lifesciences: Catalysts For 2023 And Beyond

Dec 30

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Dec 28
Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Dec 16
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences CEO Michael Mussallem to retire

Dec 08

Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Dec 04
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Nov 22
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences down 11% after Q3 misses, revised 2022 EPS guidance

Oct 27

Edwards Lifesciences (NYSE:EW) Seems To Use Debt Rather Sparingly

Sep 22
Edwards Lifesciences (NYSE:EW) Seems To Use Debt Rather Sparingly

Edwards Lifesciences wins FDA approval for PASCAL transcatheter valve repair system

Sep 15

Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching

Sep 10
Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching

Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Aug 29
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Aug 17
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Stretched Valuation And Bearish Resistance In Play

Aug 15

Edwards Lifesciences stock down ~6% after hours on Q2 results miss, slashed FY guidance

Jul 28

Edwards Lifesciences (NYSE:EW) Could Easily Take On More Debt

Jun 13
Edwards Lifesciences (NYSE:EW) Could Easily Take On More Debt

Edwards Lifesciences: Seeking 60% Upside For Potential Exit At $160 Per Share

Jun 02

Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Jun 02
Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Capital Investment Trends At Edwards Lifesciences (NYSE:EW) Look Strong

May 22
Capital Investment Trends At Edwards Lifesciences (NYSE:EW) Look Strong

Is Now The Time To Put Edwards Lifesciences (NYSE:EW) On Your Watchlist?

May 10
Is Now The Time To Put Edwards Lifesciences (NYSE:EW) On Your Watchlist?

Edwards Lifesciences Corporation (NYSE:EW) Shares Could Be 33% Above Their Intrinsic Value Estimate

Apr 29
Edwards Lifesciences Corporation (NYSE:EW) Shares Could Be 33% Above Their Intrinsic Value Estimate

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Mar 14
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Edwards Lifesciences: High Revenue Growth Already Priced In

Mar 14

Should You Investigate Edwards Lifesciences Corporation (NYSE:EW) At US$106?

Feb 20
Should You Investigate Edwards Lifesciences Corporation (NYSE:EW) At US$106?

With EPS Growth And More, Edwards Lifesciences (NYSE:EW) Is Interesting

Feb 09
With EPS Growth And More, Edwards Lifesciences (NYSE:EW) Is Interesting

Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

Jan 28
Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

Edwards LifeSciences: When Even A Pandemonium Makes Room

Jan 15

Many Would Be Envious Of Edwards Lifesciences' (NYSE:EW) Excellent Returns On Capital

Jan 06
Many Would Be Envious Of Edwards Lifesciences' (NYSE:EW) Excellent Returns On Capital

Edwards Lifesciences (NYSE:EW) Could Easily Take On More Debt

Dec 13
Edwards Lifesciences (NYSE:EW) Could Easily Take On More Debt

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Nov 17
What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

With EPS Growth And More, Edwards Lifesciences (NYSE:EW) Is Interesting

Nov 05
With EPS Growth And More, Edwards Lifesciences (NYSE:EW) Is Interesting

Many Would Be Envious Of Edwards Lifesciences' (NYSE:EW) Excellent Returns On Capital

Sep 30
Many Would Be Envious Of Edwards Lifesciences' (NYSE:EW) Excellent Returns On Capital

Is Edwards Lifesciences (NYSE:EW) Using Too Much Debt?

Sep 06
Is Edwards Lifesciences (NYSE:EW) Using Too Much Debt?

At US$111, Is Edwards Lifesciences Corporation (NYSE:EW) Worth Looking At Closely?

Aug 12
At US$111, Is Edwards Lifesciences Corporation (NYSE:EW) Worth Looking At Closely?

Does Edwards Lifesciences (NYSE:EW) Deserve A Spot On Your Watchlist?

Jul 31
Does Edwards Lifesciences (NYSE:EW) Deserve A Spot On Your Watchlist?

Edwards Lifesciences: TAVR And TMTT Strengths Key Growth Levers

Jul 28

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Jun 06
Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Edwards Lifesciences gets FDA clearance for hypotension prediction index software

Jun 01

Shareholder Returns

EWUS Medical EquipmentUS Market
7D8.2%4.7%2.9%
1Y-24.7%-8.4%-8.5%

Return vs Industry: EW underperformed the US Medical Equipment industry which returned -8.4% over the past year.

Return vs Market: EW underperformed the US Market which returned -8.5% over the past year.

Price Volatility

Is EW's price volatile compared to industry and market?
EW volatility
EW Average Weekly Movement4.1%
Medical Equipment Industry Average Movement8.6%
Market Average Movement6.8%
10% most volatile stocks in US Market17.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: EW is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: EW's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195815,700Mike Mussallemhttps://www.edwards.com

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy.

Edwards Lifesciences Corporation Fundamentals Summary

How do Edwards Lifesciences's earnings and revenue compare to its market cap?
EW fundamental statistics
Market CapUS$52.25b
Earnings (TTM)US$1.52b
Revenue (TTM)US$5.38b

34.3x

P/E Ratio

9.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EW income statement (TTM)
RevenueUS$5.38b
Cost of RevenueUS$1.08b
Gross ProfitUS$4.30b
Other ExpensesUS$2.78b
EarningsUS$1.52b

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.46
Gross Margin79.93%
Net Profit Margin28.28%
Debt/Equity Ratio10.3%

How did EW perform over the long term?

See historical performance and comparison